• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

辅助依赖型腺病毒载体在调节气道固有免疫中的潜力。

Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.

作者信息

Kushwah Rahul, Cao Huibi, Hu Jim

机构信息

Physiology and Experimental Medicine Programme, the Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada, M5G1X8.

出版信息

Cell Mol Immunol. 2007 Apr;4(2):81-9.

PMID:17484801
Abstract

Innate immune responses form the first line of defense against foreign insults and recently significant advances have been made in our understanding of the initiation of innate immune response along with its ability to modulate inflammation. In airway diseases such as asthma, COPD and cystic fibrosis, over reacting of the airway innate immune responses leads to cytokine imbalance and airway remodeling or damage. Helper-dependent adenoviral vectors have the potential to deliver genes to modulate airway innate immune responses and have many advantages over its predecessors. However, there still are a few limitations that need to be addressed prior to their use in clinical applications.

摘要

固有免疫反应构成了抵御外来侵害的第一道防线,最近我们对固有免疫反应的启动及其调节炎症的能力的理解取得了重大进展。在哮喘、慢性阻塞性肺疾病和囊性纤维化等气道疾病中,气道固有免疫反应过度会导致细胞因子失衡以及气道重塑或损伤。辅助依赖型腺病毒载体有潜力递送基因来调节气道固有免疫反应,并且相较于其前身有许多优势。然而,在将它们用于临床应用之前,仍有一些局限性需要解决。

相似文献

1
Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.辅助依赖型腺病毒载体在调节气道固有免疫中的潜力。
Cell Mol Immunol. 2007 Apr;4(2):81-9.
2
Genetic backgrounds of asthma and COPD.哮喘和 COPD 的遗传背景。
Allergol Int. 2009 Sep;58(3):315-22. doi: 10.2332/allergolint.09-RAI-0105. Epub 2009 Jul 25.
3
Innate immune response induced by gene delivery vectors.基因递送载体诱导的天然免疫反应。
Int J Pharm. 2008 Apr 16;354(1-2):9-15. doi: 10.1016/j.ijpharm.2007.06.012. Epub 2007 Jun 16.
4
Gene therapy for pulmonary diseases.肺部疾病的基因治疗。
Chest. 2006 Sep;130(3):879-84. doi: 10.1378/chest.130.3.879.
5
Inhalable siRNA: potential as a therapeutic agent in the lungs.可吸入式小干扰RNA:作为肺部治疗药物的潜力。
Mol Pharm. 2008 Jul-Aug;5(4):559-66. doi: 10.1021/mp070048k. Epub 2008 May 21.
6
Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent.A-F组的野生型腺病毒引发独特的先天免疫反应,其中HAd3和SAd23部分依赖补体。
Gene Ther. 2008 Jun;15(12):885-901. doi: 10.1038/gt.2008.18. Epub 2008 Feb 21.
7
Increased virus replication in mammalian cells by blocking intracellular innate defense responses.通过阻断细胞内固有防御反应增加哺乳动物细胞中的病毒复制。
Gene Ther. 2008 Apr;15(7):545-52. doi: 10.1038/gt.2008.12. Epub 2008 Feb 14.
8
Gene therapy progress and prospects: cystic fibrosis.基因治疗的进展与前景:囊性纤维化
Gene Ther. 2006 Jul;13(14):1061-7. doi: 10.1038/sj.gt.3302809.
9
The controversial role of adenoviral-derived vectors in gene therapy programs: where do we stand?腺病毒衍生载体在基因治疗方案中的争议性作用:我们目前的状况如何?
Drug News Perspect. 2006 Mar;19(2):99-106. doi: 10.1358/dnp.2006.19.2.977446.
10
Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators.腺病毒载体在表达 RNAi 激活剂传递中的治疗潜力。
Expert Opin Drug Deliv. 2010 Dec;7(12):1373-85. doi: 10.1517/17425247.2010.533655. Epub 2010 Nov 13.

引用本文的文献

1
RNAi therapeutic strategies for acute respiratory distress syndrome.急性呼吸窘迫综合征的 RNAi 治疗策略。
Transl Res. 2019 Dec;214:30-49. doi: 10.1016/j.trsl.2019.07.011. Epub 2019 Jul 27.
2
Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward.囊性纤维化基因治疗:回顾与展望。
Genes (Basel). 2018 Nov 7;9(11):538. doi: 10.3390/genes9110538.
3
Adenovirus: the first effective in vivo gene delivery vector.腺病毒:首个有效的体内基因递送载体。
Hum Gene Ther. 2014 Jan;25(1):3-11. doi: 10.1089/hum.2013.2527.
4
CD154 and IL-2 signaling of CD4+ T cells play a critical role in multiple phases of CD8+ CTL responses following adenovirus vaccination.CD4+T 细胞的 CD154 和 IL-2 信号在腺病毒疫苗接种后 CD8+CTL 反应的多个阶段中发挥关键作用。
PLoS One. 2012;7(10):e47004. doi: 10.1371/journal.pone.0047004. Epub 2012 Oct 5.
5
Induction of immunological tolerance to adenoviral vectors by using a novel dendritic cell-based strategy.利用新型树突状细胞策略诱导对腺病毒载体的免疫耐受。
J Virol. 2012 Apr;86(7):3422-35. doi: 10.1128/JVI.06172-11. Epub 2012 Jan 18.
6
Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives.辅助依赖性腺病毒载体的基因治疗:当前进展与未来展望。
Viruses. 2010 Sep;2(9):1886-1917. doi: 10.3390/v2091886. Epub 2010 Sep 3.
7
Gene therapy for ALI/ARDS.基因治疗急性肺损伤/急性呼吸窘迫综合征。
Crit Care Clin. 2011 Jul;27(3):705-18. doi: 10.1016/j.ccc.2011.04.002.
8
Apoptotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells.凋亡树突状细胞通过抑制树突状细胞成熟和诱导抗原特异性调节性T细胞来诱导小鼠产生耐受性。
J Immunol. 2009 Dec 1;183(11):7104-18. doi: 10.4049/jimmunol.0900824. Epub 2009 Nov 16.